MedTrace Logo

The Effect of Birth Control Methods on Anti-Mullerian Hormone (AMH) Levels

NCT01308931 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2014-08-05

No results posted yet for this study

Summary

Anti-mullerian hormone (AMH) has been shown to be a reliable marker of ovarian reserve. In prior studies, tubal ligation has been shown to have an adverse effect on ovarian reserve. One theory postulated for this effect is that the ovarian circulation is disrupted by the procedure, leading to altered hormone production. In this prospective cohort study, the investigators plan to analyze the rates of AMH decline by comparing the following contraceptive methods: tubal ligation, Essure placement, and levonorgestrel intrauterine devices (IUDs).

Conditions

  • Birth Control

Sponsors & Collaborators

  • Fertility Centers of Arizona

    collaborator OTHER

  • St. Joseph's Hospital and Medical Center, Phoenix

    collaborator OTHER

  • Valleywise Health

    lead OTHER

Principal Investigators

  • Daniel F Rychlik, MD · Maricopa Integrated Health System/Fertility Centers of Arizona

Eligibility

Min Age
25 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2015-01-31
Completion
2015-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01308931 on ClinicalTrials.gov